Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Bangladesh
· Delayed Price · Currency is BDT 216.70
-0.70 (-0.32%)
At close: Feb 5, 2025
DSE:SQURPHARMA Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 4, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 192,094 | 186,953 | 185,977 | 192,094 | 191,030 | 145,631 | Upgrade
|
| Market Cap Growth | 9.25% | 0.52% | -3.18% | 0.56% | 31.17% | -30.16% | Upgrade
|
| Enterprise Value | 125,645 | 130,781 | 132,967 | 141,464 | 147,209 | 111,668 | Upgrade
|
| Last Close Price | 216.70 | 200.44 | 189.51 | 186.54 | 180.57 | 134.54 | Upgrade
|
| PE Ratio | 8.59 | 8.93 | 9.80 | 10.58 | 11.98 | 10.91 | Upgrade
|
| Forward PE | 8.46 | 8.29 | 9.10 | 9.93 | 10.40 | 12.99 | Upgrade
|
| PS Ratio | 2.66 | 2.67 | 3.06 | 3.34 | 3.77 | 3.17 | Upgrade
|
| PB Ratio | 1.49 | 1.48 | 1.61 | 1.83 | 2.10 | 1.88 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.48 | 1.61 | 1.83 | 2.10 | 1.88 | Upgrade
|
| P/FCF Ratio | 30.35 | 13.03 | 32.71 | 28.71 | 26.61 | 16.70 | Upgrade
|
| P/OCF Ratio | 15.03 | 10.09 | 21.76 | 14.92 | 17.40 | 13.53 | Upgrade
|
| PEG Ratio | 0.68 | 0.68 | 0.70 | 0.71 | 0.69 | 0.76 | Upgrade
|
| EV/Sales Ratio | 1.74 | 1.87 | 2.19 | 2.46 | 2.90 | 2.43 | Upgrade
|
| EV/EBITDA Ratio | 5.42 | 6.38 | 7.00 | 7.57 | 8.58 | 7.07 | Upgrade
|
| EV/EBIT Ratio | 6.00 | 7.20 | 7.97 | 8.39 | 9.64 | 8.05 | Upgrade
|
| EV/FCF Ratio | 19.85 | 9.12 | 23.39 | 21.14 | 20.51 | 12.81 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.07 | 0.10 | 0.10 | 0.01 | - | Upgrade
|
| Debt / FCF Ratio | 0.17 | 0.10 | 0.35 | 0.29 | 0.01 | - | Upgrade
|
| Asset Turnover | 0.52 | 0.55 | 0.52 | 0.56 | 0.57 | 0.60 | Upgrade
|
| Inventory Turnover | 3.01 | 3.06 | 3.18 | 3.72 | 3.94 | 4.50 | Upgrade
|
| Quick Ratio | 8.96 | 10.70 | 13.29 | 14.30 | 14.56 | 10.91 | Upgrade
|
| Current Ratio | 11.41 | 13.48 | 16.67 | 17.03 | 17.33 | 14.62 | Upgrade
|
| Return on Equity (ROE) | 16.55% | 17.36% | 17.22% | 18.52% | 18.96% | 18.39% | Upgrade
|
| Return on Assets (ROA) | 8.05% | 8.93% | 8.93% | 10.17% | 10.77% | 11.26% | Upgrade
|
| Return on Capital (ROIC) | 8.42% | 9.29% | 9.30% | 10.64% | 11.34% | 11.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.92% | 14.27% | 14.19% | 15.60% | 16.55% | 17.65% | Upgrade
|
| Earnings Yield | 11.65% | 11.19% | 10.21% | 9.45% | 8.35% | 9.17% | Upgrade
|
| FCF Yield | 3.30% | 7.67% | 3.06% | 3.48% | 3.76% | 5.99% | Upgrade
|
| Dividend Yield | 5.08% | 5.49% | 5.54% | 5.36% | 3.32% | 3.33% | Upgrade
|
| Payout Ratio | 41.27% | 44.14% | 46.38% | 29.20% | 24.60% | 24.82% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | 0.00% | Upgrade
| |
| Total Shareholder Return | 5.08% | 5.49% | 5.54% | 5.36% | 3.32% | 3.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.